Topic: [ANN] CryoGen - Public sale (17.10.2017 - 01.07.2018) - page 49. (Read 23387 times)
look interesting sir! reserve indonesian translation if needed
Looks interesting. Curious to learn more. Plans for whitepaper?
huge if true 
CRYONICS – THE ADVANCED BIOTECHNOLOGIES
ICO is LIVE
WEBSITE / WHITE PAPER / TELEGRAM / TWITTER / FACEBOOK / MEDIUM / YOUTUBE
========================================
ICO CAPS
Softcap: NO SOFTCAP
Hardcap: $100 000 000 USD
TOKEN SALE: 17.10.2017 - 01.07.2018
Private-Sale: 17.10 - 06.11
Pre-ICO stage 1: 07.11 - 01.01 | Bonus : 30%
Pre-ICO stage 2: 02.01 - 31.01 | Bonus : 25%
ICO Stage 1 : 01.02 - 14.03 | Bonus : 20%
ICO Stage 2 : 15.03 - 05.04 | Bonus : 15%
ICO Stage 3 : 06.04 - 23.05 | Bonus : 10%
ICO Stage 4 : 24.05 - 01.07 | Bonus : 05%
========================================
PROBLEMS
______________
ICO is LIVE
WEBSITE / WHITE PAPER / TELEGRAM / TWITTER / FACEBOOK / MEDIUM / YOUTUBE
========================================
ICO CAPS
Softcap: NO SOFTCAP
Hardcap: $100 000 000 USD
TOKEN SALE: 17.10.2017 - 01.07.2018
Private-Sale: 17.10 - 06.11
Pre-ICO stage 1: 07.11 - 01.01 | Bonus : 30%
Pre-ICO stage 2: 02.01 - 31.01 | Bonus : 25%
ICO Stage 1 : 01.02 - 14.03 | Bonus : 20%
ICO Stage 2 : 15.03 - 05.04 | Bonus : 15%
ICO Stage 3 : 06.04 - 23.05 | Bonus : 10%
ICO Stage 4 : 24.05 - 01.07 | Bonus : 05%
========================================
Other Languages
(Links will be updated after the translation)
------------------
(Links will be updated after the translation)
------------------
| . | • Korean : (ANN, Whitepaper) • Indonesian : (ANN, Whitepaper) • Dutch : (ANN, Whitepaper) • Thai : (ANN, Whitepaper) • Polish : (ANN, Whitepaper) • Filipino: (ANN, Whitepaper) | • Japanese : (ANN, Whitepaper) • Vietnamese : (ANN, Whitepaper) • Italian : (ANN, Whitepaper) • Danish : (ANN, Whitepaper) • Russian: (ANN,Whitepaper) • Arabic: (ANN, Whitepaper) | • Spanish : (ANN, Whitepaper ) • Romanian : (ANN, Whitepaper) • Bulgarian : (ANN, Whitepaper) • Greek : (ANN, Whitepaper) • Turkish: (ANN, Whitepaper) • Croatian : (ANN, Whitepaper) | • German : (ANN, Whitepaper) • Portuguese : (ANN, Whitepaper) • Slovenian : (ANN, Whitepaper) • Hindi : (ANN, Whitepaper) • French: (ANN, Whitepaper) • Chinese Simplified : (ANN, Whitepaper) |
PROBLEMS
______________
1. Ageing as a biologically irreversible process
Every day around the world more than 150 000 people will die, some from currently incurable diseases, some by mishap from external causation, but most from the one hundred percent fatal pandemic degenerative condition simply known as ageing.
2. Absence of donor organs cryobanks
Now there is no technology for prolonged cryopreservation of donor organs and, accordingly, the problem of creating cryobanks of donor organs has not been solved, because of the logistics that will be need to support the collection, conservation and transplantation processes. It is necessary to create medical cryonics center, which combine both clinical and scientific units. In such centers, there may be cryonics storages for people in a state of cryogenic suspended animation.
3. Insufficient financing of fundamental research
Studies that have confirmed their relevance often do not continue due to a lack of adequate funding. For this reason, cryonics organizations are not sufficiently engaged in the research and development of cryonics, while in their practice they use the experience gained in the 90s of the last century and in the early 2000s.
4. Low life expectancy
Modern medicine, despite its achievements, is not able to cure all diseases. Only 50% of patients are cured of oncology. Mortality rate from strokes and cardiovascular diseases is high. In addition, because of the short period of donor organs storage, only one out of every four people that can be saved is saved.
5. Space travel
Humanity grapples with the challenges of ever-longer duration space travel. However, clearly, the life support and provisions of space travelers with nutrition during long space voyages related to huge expenses. Thus, it is necessary to create technologies for space suspended animation to make ultra-long space travel possible.
SOLUTIONS
______________
______________
CryoGen, which is created and managed by the leading cryonics company of Eurasia — KrioRus, is aimed at the large-scale development of cryonics. Cryonics is a technology of conservation of people and animals in the state of deep cooling in the hope that in the future they can be revitalized and, if necessary, cured.
This technology will also be used for reversible freezing of donor organs. In the future, cryonics will allow us to immerse astronauts in the anabiosis if there is a long voyage ahead of them.
The project uses the most advanced scientific achievements
HOW IT WORKS
______________
______________
Cryopreservation
Over the last 50 years scientist around the world has been developing and improving the technique of the cryopreservation of tissues, organs, the brain and whole organisms to make the future revival possible.
There are two kinds of cryopreservation:
• Neuropreservation, when only the brain is placed into cryonics storage.
• Whole body preservation, when the entire organism, human or animal is preserved.
Cryonics makes it possible to maintain the human body intact until scientists discover the ideal way to restore and return the patient to life and to full health.
Nowadays, there is a serious theoretical and experimental evidentiary support for the possibility of restoring biological organism and significantly prolonging a patient’s life in a relatively near future.
The funds raised under the CryoGen project will be used for the development, testing and implementation of the technology for the reversible freezing of human organs and small vertebrates in 5 or 7 years and amniotes and humans in the near future.
Feasibility is corroborated in experiments with fragments of animal organs. In February 2017, a fragment of a pig’s heart was reversibly cryopreserved, perfectly.
When this technology is fully developed, an ideal biological recovery of the body after freezing and the continuation of its vital activity will become possible.
CryoGen team has the intention of developing and implementation of:
• Vitrification (deep cooling which solidifies tissues without ice formation). We are planning to perform vitrification by means of ultra-fast cooling using cold gas blown through the whole body;
• Ultra-fast and even rewarming with the use of cryoprotectants with nanoparticles;
• New nontoxic cryoprotectants based on inert gases.
Space travel
Cryonics is our chance to get to remote planets and star systems. Human life will inevitably spread beyond the Earth to inhabit the space. The CryoGen project has all chances to become a leading project, which provides services for space anabiosis; soon our technologies can be used for space flights over long distances. So, the first step toward it has already been made.
Introduction Video
GOAL
______________
______________
The goal of the CryoGen project is to attract the attention of the world scientific community to this technology, to stimulate fundamental research of creating a completely safe thawing technology. Our activity will boost studies and researches in this field.
The results obtained during our work can be used to improve dramatically the quality and longevity of people around the world.
| . |  Cryonics facility in Switzerland |  Reversible freezing |  Cryobiological laboratories |  Space anabiosis |
SERVICES
______________
______________
| . |  DNA RETENTION 800 CRYO |  CRYOPRESERVATION OF ANIMALS 9 000 — 32 400 CRYO |  NEUROCRYOPRESERVATION 13 500 — 16 200 CRYO |
| . |  FULLBODY CRYOPRESERVATION 32 400 CRYO |  TRANSPORTATION 3000 — 9000 CRYO |  STANDBY AT THE PATIENT'S BEDSIDE 45 000 — 90 000 CRYO |
ROADMAP
______________
______________
| . |  | 2018 The opening of the CRYOGEN with the Swiss jurisdiction. 2019 Start of the mas experiments on reversible cryopreservation of animal organs. 2020 The technology of euthanasia cryonics is worked out and applied. Start of the development of technologies for reliable and effective reversible cryopreservation of the mammal organs. 2021 The technology of reliable and effective reversible cryopreservation of most mammal organs has been obtained. Experiments begin with the organs of the dying people. 2022 Anabiosis technology developing for deep space flights. |
TOKEN DETAILS
______________
______________
| . | Token name: | Cryo Token |
| . | Ticker: | CRYO |
| . | Type: | ERC20 (Ethereum Blockchain) |
| . | Total supply: | 100 000 000 CRYO |
| . | Softcap: | NO SOFTCAP |
| . | Hardcap: | $100 000 000 USD |
| . | Token Sale: | 17.10.2017 - 01.07.2018 |
| . | Accepted purchase: | ETH |
| . | Price: | 1 CRYO = $1 USD |
| . | Country: | Switzerland |
TOKEN ALLOCATION
______________
______________
| . | Token Sale | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 100% |
| . | Team | 0% |
FUNDS DISTRIBUTION
______________
______________
| . | Infrastructure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 30% |
| . | Technology development | |||||||||||||||||||||||||||||||||||||||||||||||||| 25% |
| . | Marketing, PR/GR | |||||||||||||||||||||||||||||||||||||||| 20% |
| . | Project management | |||||||||||||||||||||||||||||| 15% |
| . | Strategic partners | |||||||||| 5% |
| . | Reserve fund | |||||||||| 5% |
TOKEN SALE
______________
______________
The Cryo token is a utility token, accepted for purchase of all available services at CryoGen.
Each Cryo token is equivalent to one dollar (ICO price).
The release of tokens will be made in the amount of actually collected tokens in the pre-ICO and ICO phases of the CryoGen project.
At the same time, we expect to collect during the ICO 100,000,000 tokens at a price of 1 CRYO = $1 USD (Hardcap).
Each Cryo token is equivalent to one dollar (ICO price).
The release of tokens will be made in the amount of actually collected tokens in the pre-ICO and ICO phases of the CryoGen project.
At the same time, we expect to collect during the ICO 100,000,000 tokens at a price of 1 CRYO = $1 USD (Hardcap).